• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

临床遗传学服务中的患者赋权

Patient empowerment in clinical genetics services.

作者信息

McAllister Marion, Payne Katherine, Macleod Rhona, Nicholls Stuart, Davies Linda

机构信息

Nowgen, Manchester, UK.

出版信息

J Health Psychol. 2008 Oct;13(7):895-905. doi: 10.1177/1359105308095063.

DOI:10.1177/1359105308095063
PMID:18809640
Abstract

Outcome measurement in clinical genetics is problematic because the patient benefits are difficult to measure. The aim in this qualitative grounded theory study was to develop a theoretical framework describing the patient benefits from using clinical genetics services. Seven focus groups and 19 interviews were conducted with patients, patient group representatives, and health professionals. Data analysis resulted in construction of a model of empowerment summarizing the patient benefits from using clinical genetics services. Empowerment is similar to the concept of perceived personal control (PPC), and a measure of PPC has been developed for use in evaluations of clinical genetics services. However, empowerment includes some benefits not captured by PPC related to empowerment of other at risk relatives, and future generations.

摘要

临床遗传学中的结果测量存在问题,因为患者的获益难以衡量。这项定性扎根理论研究的目的是建立一个理论框架,描述患者使用临床遗传学服务的获益情况。我们对患者、患者群体代表和医疗专业人员进行了7个焦点小组讨论和19次访谈。数据分析得出了一个赋权模型,总结了患者使用临床遗传学服务的获益情况。赋权类似于感知到的个人控制(PPC)的概念,并且已经开发出一种PPC测量方法用于临床遗传学服务的评估。然而,赋权包括一些PPC未涵盖的获益,这些获益与其他高危亲属和后代的赋权有关。

相似文献

1
Patient empowerment in clinical genetics services.临床遗传学服务中的患者赋权
J Health Psychol. 2008 Oct;13(7):895-905. doi: 10.1177/1359105308095063.
2
Empowerment: qualitative underpinning of a new clinical genetics-specific patient-reported outcome.赋权:一种新的临床遗传学特异性患者报告结局的定性基础。
Eur J Hum Genet. 2011 Feb;19(2):125-30. doi: 10.1038/ejhg.2010.160. Epub 2010 Oct 6.
3
Personal factors associated with reported benefits of Huntington disease family history or genetic testing.与亨廷顿舞蹈症家族史或基因检测所报告的益处相关的个人因素。
Genet Test Mol Biomarkers. 2010 Oct;14(5):629-36. doi: 10.1089/gtmb.2010.0065. Epub 2010 Aug 19.
4
Genetic risks and healthy choices: creating citizen-consumers of genetic services through empowerment and facilitation.遗传风险与健康选择:通过赋权和促进来培养遗传服务的公民消费者。
Sociol Health Illn. 2010 Mar;32(3):365-81. doi: 10.1111/j.1467-9566.2009.01202.x. Epub 2009 Nov 4.
5
Evaluation of a decision aid for families considering p53 genetic counseling and testing.对考虑进行p53基因咨询和检测的家庭的决策辅助工具的评估。
Genet Med. 2006 Apr;8(4):226-33. doi: 10.1097/01.gim.0000214632.52958.01.
6
Disclosure of genetics research results after the death of the patient participant: a qualitative study of the impact on relatives.患者参与者死亡后遗传学研究结果的披露:对亲属影响的定性研究
J Genet Couns. 2007 Aug;16(4):527-38. doi: 10.1007/s10897-007-9088-1. Epub 2007 May 11.
7
Early testing for Huntington disease in children: pros and cons.儿童亨廷顿病的早期检测:利弊
J Child Neurol. 2010 Apr;25(4):482-4. doi: 10.1177/0883073809343315. Epub 2009 Oct 6.
8
Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups.三个种族有风险亲属中获得遗传咨询和结直肠癌基因检测意向的相关因素。
Cancer Epidemiol Biomarkers Prev. 1999 Apr;8(4 Pt 2):329-36.
9
Protocol for stage 1 of the GaP study (Genetic testing acceptability for Paget's disease of bone): an interview study about genetic testing and preventive treatment: would relatives of people with Paget's disease want testing and treatment if they were available?GaP研究(骨佩吉特病的基因检测可接受性)第一阶段方案:一项关于基因检测和预防性治疗的访谈研究:骨佩吉特病患者的亲属如果有机会,会希望接受检测和治疗吗?
BMC Health Serv Res. 2006 Jun 8;6:71. doi: 10.1186/1472-6963-6-71.
10
Genetic susceptibility testing for Alzheimer disease: motivation to obtain information and control as precursors to coping with increased risk.阿尔茨海默病的基因易感性检测:获取信息和掌控感的动机作为应对风险增加的先兆。
Patient Educ Couns. 2006 Dec;64(1-3):259-67. doi: 10.1016/j.pec.2006.03.002. Epub 2006 Jul 21.

引用本文的文献

1
Empowerment of parents of infants with congenital heart disease after rapid genome sequencing : April 11, 2025, revised June 20, 2025.快速基因组测序后先天性心脏病患儿家长的赋权:2025年4月11日,2025年6月20日修订
J Community Genet. 2025 Jul 14. doi: 10.1007/s12687-025-00813-3.
2
dVP_FAM-development and evaluation of a transsectoral digital care platform for individuals with familial cancer risks: study protocol for a multi-centre, cluster-randomised, mixed-methods study.dVP_FAM:针对有家族性癌症风险个体的跨部门数字护理平台的开发与评估:一项多中心、整群随机、混合方法研究的研究方案
Trials. 2025 Jun 2;26(1):185. doi: 10.1186/s13063-025-08872-0.
3
Exploring the potential usefulness of the GCOS-16 for expanded applications.
探索GCOS-16在扩展应用方面的潜在用途。
Eur J Hum Genet. 2025 May;33(5):642-648. doi: 10.1038/s41431-025-01830-z. Epub 2025 Mar 22.
4
Need for specially designed educational support groups: Young women's experiences of being identified with BRCA pathogenic variants.对专门设计的教育支持小组的需求:年轻女性被鉴定携带BRCA致病变异体的经历
J Genet Couns. 2025 Apr;34(2):e1980. doi: 10.1002/jgc4.1980. Epub 2024 Sep 28.
5
Translation, cross-cultural adaptation, and preliminary validation of a patient-reported outcome measure for genetic counseling outcomes in Sweden.瑞典遗传咨询结果患者报告结局指标的翻译、跨文化调适及初步验证
J Genet Couns. 2025 Feb;34(1):e1896. doi: 10.1002/jgc4.1896. Epub 2024 Apr 26.
6
Personalising genetic counselling (POETIC) trial: Protocol for a hybrid type II effectiveness-implementation randomised clinical trial of a patient screening tool to improve patient empowerment after cancer genetic counselling.个体化遗传咨询(POETIC)试验:一种混合 II 型有效性-实施随机临床试验的方案,该试验使用一种患者筛查工具来改善癌症遗传咨询后的患者授权。
Trials. 2023 Nov 8;24(1):712. doi: 10.1186/s13063-023-07723-0.
7
Evolving cardiovascular genetic counseling needs in the era of precision medicine.精准医学时代不断演变的心血管遗传咨询需求。
Front Cardiovasc Med. 2023 Jun 23;10:1161029. doi: 10.3389/fcvm.2023.1161029. eCollection 2023.
8
Parents' expectations, preferences, and recall of germline findings in a childhood cancer precision medicine trial.父母对儿童癌症精准医学试验中种系研究结果的期望、偏好和回忆。
Cancer. 2023 Nov 15;129(22):3620-3632. doi: 10.1002/cncr.34917. Epub 2023 Jun 29.
9
Using Rasch measurement theory to explore the fitness for purpose of the genetic counseling outcome scale: a tale of two scales.运用拉什测量理论探究遗传咨询结果量表的适用性:两个量表的故事。
Qual Life Res. 2023 Mar;32(3):895-904. doi: 10.1007/s11136-022-03289-7. Epub 2022 Nov 21.
10
Outcomes of Importance to Patients in Reproductive Genetic Carrier Screening: A Qualitative Study to Inform a Core Outcome Set.生殖遗传携带者筛查中对患者重要的结局:一项用于确定核心结局集的定性研究
J Pers Med. 2022 Aug 12;12(8):1310. doi: 10.3390/jpm12081310.